Granted Patent
B2
US 12,723,034 · App. 19/381,972 · Granted Sep 1, 2026
Crystalline form of epigallocatechin-3-gallate
Inventors:
George David McClure, Jr. (Huntsville, AL); Peter York (Bradford, GB); Steven Thomas Nicholson (Bradford, GB); Linda Sharon Daintree (Bradford, GB); Aishah Ashraf (Bradford, GB)
Assignee:
PharmassětX Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The disclosure relates to crystalline Form X of epigallocatetchin-3-gallate, compositions containing Form X, and methods of using Form X. The disclosure also relates to methods of making crystalline Form X of epigallocatetchin-3-gallate.
Claims (1)
1 . Crystalline Form X epigallocatechin-3-gallate characterized by an X-ray diffraction (XRPD) pattern having peaks at 6.4° , 9.7° , and 10.6° 2θ (±0.2° 2θ).
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 6, 2026
From: MCCLURE, GEORGE DAVID, JR., DR.; NICHOLSON, STEVEN THOMAS; ASHRAF, AISHAH; DAINTREE, LINDA SHARON; YORK, PETER
To: PHARMASSÊTX INC.
Reel/Frame 073990/0553 →
Continuity (2)
Provisional Application
63718303
· Nov 8, 2024
References Cited (21)
US 8471044B2
· Zaworotko
· 2013
[cited by examiner]
CN 109293617A
· 2019
[cited by applicant]
WO 9501221A1
· 1995
[cited by applicant]
WO 9600610A1
· 1996
[cited by applicant]
WO 9836825A1
· 1998
[cited by applicant]
WO 9944733A1
· 1999
[cited by applicant]
WO 9959710A1
· 1999
[cited by applicant]
WO 0103821A1
· 2001
[cited by applicant]
WO 2008153938A2
· 2008
[cited by applicant]
WO 2015136551A2
· 2015
[cited by applicant]
WO 2025008082A1
· 2025
[cited by applicant]
Anish V. Dighe, et al., Crystal Growth & Design 2022 22 (5), 3119-3127. (Year: 2022).
[cited by examiner]
Gaesser, Glenn A., et al. American Journal of Lifestyle Medicine 6.1 (2012): 4-13 (abstract). (Year: 2012).
[cited by examiner]
Brittain, Harry G. “Polymorphism in pharmaceutical solids.” Drugs and the pharmaceutical sciences 95 (1999): 331-361. (Year: 1999).
[cited by examiner]
CN109293617—google translation, printed May 14, 2026. (Year: 2026).
[cited by examiner]
Adam J. Smith et al., Mol. Pharmaceutics 2013, 10, 2948-2961. (Year: 2013).
[cited by examiner]
Li, et al., “The physical and chemical stability of amorphouse (-)-epi-gallocatechin gallate: Effects of water vapor sorption and storage temperature”, Food Research International 58, journal hompage: www.elsevier.com/l…
[cited by applicant]
Smith, et al., “Crystal Engineering of Green Tea Epigallocatechin-3-gallate (EGCg) Cocrystals and Pharmacokinetic Modulation in Rats”, Molecular Pharmaceutics, pubs.acs.org/molecularpharmaceutics, pp. 2948-2961, (2013).
[cited by applicant]
International Search Report and Written Opinion of the International Searching Authority in related International Application No. PCT/US2025/054541 dated Mar. 11, 2026.
[cited by applicant]